Universal Health Services (UHS) 132.03 $UHS Universal

New Post Public Reply Private Reply Replies (0) Message Board
Stock_Tracker
Universal Health Services (UHS) 132.03 $UHS

Universal Health Services Has Returned 21.2% Since SmarTrend Recommendation (UHS)
Comtex SmarTrend(R) - Fri Jun 10, 1:45PM CDT
SmarTrend identified an Uptrend for Universal Health Services (NYSE:UHS) on February 26th, 2016 at $112.10. In approximately 4 months, Universal Health Services has returned 21.19% as of today's recent price of $135.85.
UHS: 132.03 (-3.14)

SmarTrend Watching for Potential Pullback in Shares of Universal Health Services After 1.09% Gain
Comtex SmarTrend(R) - Wed Jun 08, 1:37PM CDT
Universal Health Services (NYSE:UHS) traded in a range yesterday that spanned from a low of $137.71 to a high of $139.34. Yesterday, the shares gained 1.1%, which took the trading range above the 3-day high of $138.00 on volume of 542,000 shares. Often times after large one-day gains, short term traders will seek to take profits and, as such, investors should be cautious.
UHS: 132.03 (-3.14)

Universal Health Services Rises 1.09% on Heavy Volume: Watch For Potential Pullback
Comtex SmarTrend(R) - Wed Jun 08, 1:35PM CDT
Universal Health Services (NYSE:UHS) traded in a range yesterday that spanned from a low of $137.71 to a high of $139.34. Yesterday, the shares gained 1.1%, which took the trading range above the 3-day high of $138.00 on volume of 542,000 shares. Often times after large one-day gains, short term traders will seek to take profits and, as such, investors should be cautious.
UHS: 132.03 (-3.14)

Technical Report on Hospitals Stocks -- HCA Holdings, Tenet Healthcare, Universal Health Services, and Select Medical Holdings
PR Newswire - Mon Jun 06, 7:45AM CDT
On Friday, June 03, 2016, the NASDAQ Composite ended the trading session at 4,942.52, down 0.58%; the Dow Jones Industrial Average lost 0.18% to finish at 17,807.06; and the S&P 500 closed at 2,099.13, down 0.29%. ActiveWallSt.com has initiated coverage on the following equities: HCA Holdings Inc. (NYSE: HCA), Tenet Healthcare Corporation (NYSE: THC), Universal Health Services Inc. (NYSE: UHS), and Select Medical Holdings Corporation (NYSE: SEM). Learn more about these stocks by accessing their free trade alerts at:
HCA: 77.95 (-1.60), THC: 27.69 (-1.21), UHS: 132.03 (-3.14), SEM: 11.51 (-0.25)

Universal Health Services, Inc. To Present At The 37th Annual Goldman Sachs Global Healthcare Conference
PR Newswire - Fri Jun 03, 1:57PM CDT
Universal Health Services, Inc. (NYSE: UHS) announced today that Steve Filton, Senior Vice President and Chief Financial Officer will present at the 37th Annual Goldman Sachs Global Healthcare Conference in Rancho Palos Verdes, CA on Tuesday, June 7, 2016 at 3:20 pm Pacific Time. A live audio webcast of the presentation will be available on the Company's website (www.uhsinc.com). For those unable to listen to the live webcast, a replay will be available on the Company's website for 90 days following the conference.
UHS: 132.03 (-3.14)

Universal Health Services Shares Up 21.7% Since SmarTrend's Buy Recommendation (UHS)
Comtex SmarTrend(R) - Fri Jun 03, 1:55PM CDT
SmarTrend identified an Uptrend for Universal Health Services (NYSE:UHS) on February 26th, 2016 at $112.10. In approximately 3 months, Universal Health Services has returned 21.66% as of today's recent price of $136.37.
UHS: 132.03 (-3.14)

Universal Health Services Up 21.4% Since SmarTrend Uptrend Call (UHS)
Comtex SmarTrend(R) - Wed May 25, 1:58PM CDT
SmarTrend identified an Uptrend for Universal Health Services (NYSE:UHS) on February 26th, 2016 at $112.10. In approximately 3 months, Universal Health Services has returned 21.43% as of today's recent price of $136.12.
UHS: 132.03 (-3.14)

After Yesterday's Decline of 1.75%, Universal Health Services Offers Investors Better Value
Comtex SmarTrend(R) - Mon May 23, 12:47PM CDT
Universal Health Services (NYSE:UHS) traded in a range yesterday that spanned from a low of $131.52 to a high of $133.76. Yesterday, the shares fell 1.8%, which took the trading range below the 3-day low of $132.16 on volume of 649,000 shares. Often times after large one-day declines, short-term traders may play for some degree of mean reversion.
UHS: 132.03 (-3.14)

Universal Health Services, Inc. Announces Dividend
PR Newswire - Thu May 19, 4:00PM CDT
Universal Health Services, Inc. (NYSE: UHS) announced today that its Board of Directors voted to pay a cash dividend of $0.10 per share on June 15, 2016 to shareholders of record as of June 1, 2016.
UHS: 132.03 (-3.14)

Universal Health Services, Inc. Announces Offering Of Senior Secured Notes
PR Newswire - Thu May 19, 8:11AM CDT
Universal Health Services, Inc. (NYSE: UHS) today announced an offering of $800 million aggregate principal amount of 4.750% senior secured notes due 2022 ("New 2022 Notes" and senior secured notes due 2026 (the "2026 Notes" and, together with the New 2022 Notes, the "Notes". The New 2022 Notes will be issued as additional notes under the indenture governing our existing $300 million aggregate principal amount of 4.750% Senior Secured Notes due 2022, issued on August 7, 2014 (the "Existing 2022 Notes". The New 2022 Notes and the Existing 2022 Notes will have identical terms, other than the issue date, the issue price and the first interest payment date, and the New 2022 Notes will constitute part of the same series as the Existing 2022 Notes. The New 2022 Notes will have the same CUSIP numbers as the Existing 2022 Notes, except for the Notes sold pursuant to Regulation S which will, on the 40th day following the issue date of the Notes, have the same CUSIP numbers. The New Notes that have the same CUSIP numbers as the Existing 2022 Notes will be fungible with the Existing 2022. The 2026 Notes will be a new issuance under a separate indenture. The Company intends to use the net proceeds of the offering to refinance existing indebtedness.
UHS: 132.03 (-3.14)

Universal Health Services, Inc. To Present At The UBS Global Healthcare Conference
PR Newswire - Tue May 17, 3:17PM CDT
Universal Health Services, Inc. (NYSE: UHS) announced today that Steve Filton, Senior Vice President and Chief Financial Officer will present at the UBS Global Healthcare Conference in New York, NY on Monday, May 23, 2016 at 2:30 pm Eastern Time. A live audio webcast of the presentation will be available on the Company's website (www.uhsinc.com). For those unable to listen to the live webcast, a replay will be available on the Company's website for 180 days following the conference.
UHS: 132.03 (-3.14)

Moving Average Crossover Alert: Universal Health Services (UHS)
Zacks Equity Research - Zacks Investment Research - Fri May 13, 10:13AM CDT
Universal Health Services Inc. (UHS) is looking like an interesting pick from a technical perspective, as the company is seeing favorable trends on the moving average crossover front
UHS: 132.03 (-3.14)

Universal Health Services, Inc. To Present At The Bank of America Merrill Lynch 2016 Healthcare Conference
PR Newswire - Thu May 05, 3:16PM CDT
Universal Health Services, Inc. (NYSE: UHS) announced today that Alan B. Miller, Chairman and Chief Executive Officer will present at the Bank of America Merrill Lynch 2016 Healthcare Conference in Las Vegas, NV on Thursday, May 12, 2016 at 10:00 AM Pacific Time. A live audio webcast of the presentation will be available on the Company's website (www.uhsinc.com). For those unable to listen to the live webcast, a replay will be available on the Company's website for 90 days following the conference.
UHS: 132.03 (-3.14)

Universal Health Services, Inc. Announces Purchase Of Third-Party Minority Ownership Interests In Six Acute Care Hospitals In Las Vegas, Nevada
PR Newswire - Mon May 02, 3:22PM CDT
Universal Health Services, Inc. (NYSE: UHS) announced today that it has agreed to purchase the minority ownership interests held by a third-party in its six acute care hospitals located in Las Vegas, Nevada. In connection with this transaction, the Company will make an aggregate cash payment of $445 million to the third-party which includes both the purchase price and return of capital.
UHT: 56.42 (+0.56), UHS: 132.03 (-3.14)

Universal Health (UHS) Tops Q1 Earnings on Strong Sales
Zacks Equity Research - Zacks Investment Research - Mon May 02, 5:53AM CDT
Universal Health Services Inc. (UHS) reported first-quarter 2016 adjusted earnings of $1.98 per share, which beat the Zacks Consensus Estimate by 12 cents.
BAX: 44.41 (-0.08), UHS: 132.03 (-3.14), BEAT: 16.62 (-0.07), EW: 101.13 (-0.39)

The Top Performing Healthcare ETF of The Week
Brian Feroldi, The Motley Fool - Motley Fool - Sat Apr 30, 5:00AM CDT
It was a rough week to be a healthcare-focused investor, as every single one of the most popular exchange-traded funds that focus on the space ended the week in the red. It was such a rotten week that the many of these ETFs lost 3% or more of their...
IHF: 126.51 (-1.67), UHS: 132.03 (-3.14)

Universal Health Services posts 1Q profit
Automated Insights - Wed Apr 27, 3:37PM CDT
KING OF PRUSSIA, Pa. (AP) _ Universal Health Services Inc. (UHS) on Wednesday reported first-quarter profit of $190.8 million.
UHS: 132.03 (-3.14)

Watch for Universal Health Services to Potentially Pullback After Gaining 2.79% Yesterday
Comtex SmarTrend(R) - Tue Apr 26, 1:39PM CDT
Universal Health Services (NYSE:UHS) traded in a range yesterday that spanned from a low of $129.97 to a high of $133.11. Yesterday, the shares gained 2.8%, which took the trading range above the 3-day high of $130.33 on volume of 751,000 shares. Often times after large one-day gains, short term traders will seek to take profits and, as such, investors should be cautious.
UHS: 132.03 (-3.14)

Scroll down for more posts ▼

Top 10 Most Recent News Articles

Taiwan Fuses Ancient TCM with Modern Bio Tech in 2026

Updated Category News Views 244

The Dynamic Fusion of Heritage and Innovation When you think about it, mixing centuries-old herbal wisdom with today's cutting-edge biotech might sound like a plot twist, but that's exactly what's cooking in Taiwan. Over at SupplySide Global 2026 in Las Vegas, Taiwan's got something more than just traditional medicine to flaunt; it's showcasing an impressive fusion of...

Continue Reading
Survivors Secure $800M Settlement with NY Archdiocese

Updated Category News Views 189

Massive Settlement: A Long-Awaited Justice Here's a different kind of news that's hitting like a thunderbolt. Over 1,300 survivors of abuse have finally struck a landmark deal with the Archdiocese of New York. Not only are the numbers staggering, but the relief for these individuals is palpable. We're talking about more than $800 million on the table here. That's some...

Continue Reading
CapCut's Role in AI-Assisted Small Biz Marketing

Updated Category News Views 0

In today's fast-paced digital world, small businesses lament the constant hustle to stay relevant online. This juggling act with limited resources often makes effective marketing feel like a high-wire circus performance. Enter AI tools, promising to lighten the load, and CapCut stands out as a game-changer. AI Tools Revolutionizing Small Business Marketing Amid growing...

Continue Reading
Master Sommeliers and Italian Producers Clash on Wine Lists

Updated Category News Views 166

Wines Jockeying for New York’s Coveted Lists Alright, picture a stage set up in New York City like an arena. But instead of gladiators, you've got master sommeliers on one side and Italian wine producers on the other, each armed with their own arguments. They're locked in a battle over what it really takes to get a bottle imbedded on a New York City's prestigious wine...

Continue Reading
Ping An's Bold Green Moves Ahead of APEC 2026

Updated Category News Views 92

Ping An's Pitch for Green: Talking the Talk and Walking the Walk? Well, here's something cooking in Shenzhen at the Ping An Finance Center—an international seminar championing green development initiatives. It's all buzz around Ping An Insurance (HKEX: 2318; SSE: 601318) flexing its green muscle, orchestrating conversations right before APEC 2026. Talk about timing....

Continue Reading
Innovent's IBI3001 Shows Promise in Phase 1 Trials

Updated Category News Views 139

Pioneering Path with IBI3001 at ESMO 2026 Navigating through the crowded landscape of oncology trials, Innovent Biologics recently rolled out some riveting Phase 1 clinical data for their new darling, IBI3001. Top brass from Innovent took to the European Society for Medical Oncology (ESMO) Congress stage to lay bare their findings. Obviously, when you're presenting a...

Continue Reading
Aluminum Design Fumble: Geometry Over Wall Thickness

Updated Category News Views 218

A Misstep in Aluminum Design Practices Well, here's a nugget of wisdom for the metal enthusiasts out there—stop beefing up aluminum components with thicker walls and focus on smart geometry. This isn't a drill, folks. Mark Coyle, a seasoned mind over at American Custom Metals, has been waving the flag for smarter aluminum design methods right from Rochester, NY, and...

Continue Reading
CSTS Unveils PremierX in NYC: A Bold Entertainment Move

Updated Category News Views 228

Welcome to the New Era of Entertainment Out of the blockbusters and into the open air, eh? On October 30, 2026, CSTS Enterprises flipped the New York skyline into a canvas for their grand kickoff of PremierXTM—a live entertainment brand poised to redefine how we gobble up our music, sport, and art. Now, there's a shot of adrenaline New Yorkers weren't exactly begging...

Continue Reading
World Young Scientist Summit 2026 in Wenzhou Kicks Off

Updated Category News Views 190

Young Minds Meet AI Innovation Crack open the playbook, and it's clear: young brains from across the globe are gathering in Wenzhou, Zhejiang, China, to wrangle with AI and chart the course of science toward a sustainable future. The World Young Scientist Summit 2026 isn't just a parade of speeches and accolades. Nah, it's a deep dive into where innovative minds believe...

Continue Reading
Innovent's IBI354: New Data Spurs Hope for HER2+ BC

Updated Category News Views 98

Innovent Lauds HER2 ADC's Moment at ESMO 2026 Alright, chin up, investors. At the 2026 ESMO Congress, Innovent's throwing down some promising Phase 2 data for their brainchild, IBI354. You hear that name and it's like hearing about a rock star in the making in the oncology world. The potential here isn’t just talk—it's a loud, resounding call for attention. Their...

Continue Reading

Top 5 Most Recently Viewed Articles

Exploring Opportunities in Oversold Tech Stocks Today

Updated Category News Views 121

Market Dynamics and Oversold Stocks Recently, we witnessed a notable sell-off in the stock market, which was fueled by rising concerns surrounding the AI industry. As a result, many stocks experienced a significant pullback. Interestingly, this downturn did not discriminate and impacted various equities, including those unrelated to the AI sector. It's essential to...

Continue Reading
Innovative Device Revolutionizes Leg Recovery Process

Updated Category News Views 109

A Breakthrough in Leg Recovery: The LEG LIFTER Recovering from an injury or surgery can be a challenging process, especially when it comes to managing mobility. An inventive entrepreneur has come up with a unique solution to assist those dealing with leg injuries. The designer, based in Marietta, has developed the LEG LIFTER, a tool aimed at facilitating the lifting and...

Continue Reading
Vizsla Silver's New Strategic Acquisition Enhances Panuco Project

Updated Category News Views 78

Vizsla Silver Expands its Footprint with Key Acquisition In an exciting development, Vizsla Silver Corp. (NYSE: VZLA) (TSX: VZLA) has entered into an agreement to acquire significant claims that will bolster its already promising Panuco project. Ten new claims totaling 2,378 hectares have been purchased from Minera Fresnillo S.A. de C.V., a Fresnillo plc subsidiary. This...

Continue Reading
C3.ai Investors Seek Justice Amid Recent Stock Concerns

Updated Category News Views 91

Understanding the Situation for C3.ai Investors C3.ai, Inc. (NYSE: AI) has recently made headlines, not for positive advancements, but due to significant concerns regarding its stock performance and allegations of misleading statements. Shareholders who purchased shares during a specific class period might have encountered substantial losses, prompting the need for...

Continue Reading
Class Action Alert for Investors of Regeneron Pharmaceuticals

Updated Category News Views 139

Investors of Regeneron Pharmaceuticals Urged to Act In the bustling world of biotechnology, Regeneron Pharmaceuticals, Inc. (NASDAQ: REGN) has captured significant attention. Recently, the exceptionally reputable Rosen Law Firm announced a class action lawsuit, bringing notice to shareholders who have purchased securities from November 2, 2023, to October 30, 2024. This...

Continue Reading